Colgate/$CL
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Colgate
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.
- Ticker
- $CL
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 33,600
- Headquarters
- New York, United States
- Website
- www.colgatepalmolive.com
Colgate Metrics
BasicAdvanced
$76B
37.34
$2.56
0.32
$2.10
2.22%
Price and volume
Market cap
$76B
Beta
0.32
52-week high
$99.33
52-week low
$75.00
Average daily volume
4.9M
Dividend rate
$2.10
Financial strength
Current ratio
0.958
Quick ratio
0.575
Long term debt to equity
11.225
Total debt to equity
12.056
Dividend payout ratio (TTM)
89.19%
Interest coverage (TTM)
17.59%
Profitability
EBITDA (TTM)
5,041
Gross margin (TTM)
60.64%
Net profit margin (TTM)
9.65%
Operating margin (TTM)
20.66%
Effective tax rate (TTM)
26.76%
Revenue per employee (TTM)
$630,000
Management effectiveness
Return on assets (TTM)
16.05%
Return on equity (TTM)
231.74%
Valuation
Price to earnings (TTM)
37.339
Price to revenue (TTM)
3.598
Price to book
263.92
Price to tangible book (TTM)
-17.83
Price to free cash flow (TTM)
20.21
Free cash flow yield (TTM)
4.95%
Free cash flow per share (TTM)
4.731
Dividend yield (TTM)
2.20%
Forward dividend yield
2.22%
Growth
Revenue change (TTM)
5.91%
Earnings per share change (TTM)
-28.27%
3-year revenue growth (CAGR)
3.61%
10-year revenue growth (CAGR)
3.31%
3-year earnings per share growth (CAGR)
10.38%
10-year earnings per share growth (CAGR)
5.30%
3-year dividend per share growth (CAGR)
3.39%
10-year dividend per share growth (CAGR)
3.15%
What the Analysts think about Colgate
Analyst ratings (Buy, Hold, Sell) for Colgate stock.
Analyst projections of the future price of Colgate stock.
Bulls say / Bears say
Colgate beat third-quarter expectations and raised its 2026 outlook: it now expects 5%–7% base-business EPS growth and higher gross margins. Organic sales grew 3.6%, and management said worldwide volume improved for a fourth consecutive quarter. (Colgate-Palmolive, Boursorama)
Hill’s Pet Nutrition delivered 5.7% organic growth in the third quarter, with volume up 1.8% despite the drag from exiting private-label pet food. That business now represents 22% of sales and grew faster than Colgate’s total sales. (Colgate-Palmolive, PetfoodIndustry)
Colgate’s geographic and category breadth is supporting growth beyond its weak North American business: Latin America organic sales rose 6.0%, while Asia-Pacific grew 4.6% and Europe, Middle East and Africa 2.7%. It also retained leading global shares in toothpaste and manual toothbrushes, at 41.4% and 33.1% year to date. (Colgate-Palmolive)
North America remains a clear weak spot: third-quarter organic sales fell 1.6% as volume dropped 3.7%, and operating profit fell 11%. Reuters previously reported market-share losses, competition and retailer inventory cuts weighing on the region. (Colgate-Palmolive, Reuters)
Input-cost pressure could limit further margin gains: raw and packaging materials cut third-quarter gross margin by 300 basis points, nearly matching productivity savings, and management expects elevated commodity and logistics costs into early 2027. Higher freight costs hit earnings quickly, while tariffs are also adding pressure. (Colgate-Palmolive, Reuters)
Third-quarter organic sales growth still relied more on pricing than volume: pricing added 2.0 percentage points against 1.7 points from volume. At Hill’s, 3.9% pricing outpaced 1.8% volume growth while its operating margin slipped 20 basis points, leaving less room if pricing becomes harder to sustain. (Colgate-Palmolive)
Data summarised monthly by Lightyear AI. Last updated on 30 Oct 2026.
Colgate Financial Performance
Revenues and expenses
Colgate Earnings Performance
Company profitability
Upcoming events
Colgate News
AllArticlesVideos
Funds containing Colgate
AllUSDEURGBP
Fund name | Fund size | $CL weighting |
|---|---|---|
iShares S&P 500 Consumer Staples Sector€2B7D | $533M | 2.33% |
iShares S&P 500 Consumer Staples Sector£ICSU | $533M | 2.33% |
SPDR MSCI World Consumer Staples$WCOS | $157M | 1.52% |
Xtrackers MSCI World Consumer Staples$XDWS | $926M | 1.51% |
Xtrackers MSCI World Consumer Staples£XWCS | $926M | 1.51% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.